MOHAMMAD YOUSAF: Open Payments
NPI 1801844303 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,107 in 127 payments from 18 companies in 2025. Trend: 2023 $1,128 · 2024 $1,457 · 2025 $2,107
Food & beverage: $2,107
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 33 | $517 |
| AstraZeneca Pharmaceuticals LP | 14 | $346 |
| Amgen Inc. | 21 | $263 |
| ABBVIE INC. | 13 | $193 |
| Novartis Pharmaceuticals Corporation | 8 | $151 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $147 |
| Corcept Therapeutics | 3 | $73 |
| Astellas Pharma US Inc | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 6 | $62 |
| Dexcom, Inc. | 3 | $58 |
Products named: Ozempic, Rybelsus, LEQVIO, FARXIGA, XIFAXAN, AIRSUPRA, UBRELVY, Wegovy.
Industry payments across WV — which companies pay providers there.
